𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New drug for skin diseases

Publisher
Elsevier Science
Year
1958
Tongue
English
Weight
150 KB
Volume
266
Category
Article
ISSN
0016-0032

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

New drugs in rheumatic disease
New drugs in rheumatic disease
✍ Glenn M. Clark πŸ“‚ Article πŸ“… 1962 πŸ› John Wiley and Sons 🌐 English βš– 284 KB πŸ‘ 2 views

RECENT YEARS there has been an increasing trend toward the rapid I introduction of "new and more potent" therapeutic agents in the field of rheumatology. Many of these have no proven qualitative differences on comparison with the "newer and more potent agents" of other years. Before joining the rush

Antioxidant activity, lipid peroxidation
Antioxidant activity, lipid peroxidation and skin diseases. What's new
✍ S Briganti; M Picardo πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## ABSTRACT Due to its interface function between the body and the environment, the skin is chronically exposed to both endogenous and environmental pro‐oxidant agents, leading to the harmful generation of reactive oxygen species (ROS). There is compelling evidence that oxidative stress is involved

Coupled vehicle–skin models for drug rel
Coupled vehicle–skin models for drug release
✍ S. Barbeiro; J.A. Ferreira πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 382 KB

Percutaneous absorption of a drug delivered by a vehicle source is usually modeled by using diffusion Fick's law. In this case, the model consists in a system of partial differential equations of diffusion type with a compatibility condition on the transition boundary between the vehicle and the ski